The upcoming RDD Europe 2025 conference in Estoril, Portugal will mark the 20th anniversary of the first RDD Europe meeting, which took place in Paris in 2005. Co-organized by RDD Online and Aptar Pharma, the conference will take place May 6-9 and will once again include podium sessions, workshops, a poster exhibit, and a tabletop technology exhibition covering topics related to inhaled and nasal drug delivery.
This year’s edition of RDD Europe is the second to take place at the Estoril Congress Center, which previously hosted the conference in 2019. RDD Online’s Richard Dalby says that the location proved popular the first time, and the organizers anticipate that the 2025 edition will draw a capacity attendance of more than 500. More than 72 posters will be presented, and participation in the technology exhibition is currently very near capacity, with about 70 companies signed up to exhibit products and services.
For anyone unable to attend the meeting in person, RDD Europe is offering an on-demand registration that will allow access to workshops and posters April 29 through June 30, 2025 and to recorded presentations from mid-May through June.
While the full program has not yet been announced, the Knowledge Spaces for RDD Europe 2025 are:
- Advanced Inhalation
- Aqueous Agenda
- Bench to Bedside
- Inspiring Dry Powder Inhalation
- MDIs in Transition
- Nasal Spotlight
Dalby highlights scheduled talks by Jag Shur of RIGImmune on non-lipid nanoparticle delivery of RNA therapeutics; Jan de Backer of Fluidda on the regulatory landscape for simulation; Regina Scherließ of Kiel University on engineered lactose carriers; Will Ganley of Nanopharm on nose-to-brain delivery; and David Lewis of OzUK on design of solution MDIs with LGWP propellants. The full program will be published on this page when it becomes available.
The scientific program also includes a Posters on the Podium session, with the presentation of the VCU RDD Peter R. Byron Graduate Student Award, and a workshop session. Delegates can choose to attend 3 of these 12 60-minute workshops:
- Aptar Pharma and Pulmotree: Ready for Clinical Trials in 1 Hour: A Roadmap to Success
- Bespak and H&T Presspart: The Transition To Low GWP Propellants In pMDIs – Increasing Your Probability of Success Using a Collaborative Approach
- Catalent: Biologics for Nebulization: An Approach to Formulate and Manufacture
- Copley Scientific: Unlock the Mysteries of APSD Data Analysis: Transform Your Inhaled Product Development
- INTO: A Systematic and Efficient Approach Through Use of a Complimentary Expertise to Mitigate Uncertainty and Accelerate Dry Powder Inhaler Development
- Honeywell: Navigating the Global Regulatory Landscape Enabling the Sustainability Transition in the pMDI Space
